Printer Friendly

Browse Dabigatran etexilate topic

Articles

1-24 out of 24 article(s)
Title Author Type Date Words
Boehringer Ingelheim's Pradaxa oral pellets for children receive US FDA approval. Jun 22, 2021 209
Boehringer Ingelheim's Pradaxa oral pellets for children receive US FDA approval. Jun 22, 2021 210
Direct-Acting Oral Anticoagulants. Inocian, Ergie P.; Patterson, Kathryn; Reynaldo, Rhea Faye D. Felicilda Nov 1, 2020 2690
The Predictive Value of Growth Differentiation Factor-15 in Recurrence of Atrial Fibrillation after Catheter Ablation. Wei, Ying; Liu, Shuwang; Yu, Haiyi; Zhang, Yuan; Gao, Wei; Cui, Ming; Li, Lei Aug 31, 2020 6823
Use of Idarucizumab to Revert the Anticoagulant Effect of Dabigatran in Heart Transplant Surgery: An Institutional Experience. Herrera-Escandon, Alvaro; Castano-Cifuentes, Orlando; Plata-Mosquera, Carlos A. Mar 31, 2020 1758
Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation. Pridavkova, Dana; Samos, Matej; Bolek, Tomas; Skornova, Ingrid; Zolkova, Jana; Kubisz, Peter; Stasko Dec 31, 2019 9542
Analysis on the Global Market for Cardiovascular Drugs (2014-2022): Size & Growth, Segmentation, Competitive Landscape, Market Shares, Trends & Strategies. Sep 25, 2019 928
Boehringer Ingelheim--Dabigatran's safety and efficacy established for management of VTE in children 9/7/2019. Jul 19, 2019 320
Boehringer Ingelheim--Dabigatran's safety and efficacy established for management of VTE in children--9/7/2019. Jul 10, 2019 320
An Unusual Side Effect of Dabigatran Etexilate Use - Acute Renal Failure. Gurmen, Ekim Saglam; Bilge, Adnan Jun 1, 2019 1246
Reversal Strategies for Intracranial Hemorrhage Related to Direct Oral Anticoagulant Medications. Dabi, Alok; Koutrouvelis, Aristides P. Report Jan 1, 2018 7718
Investigation of Interactions between Thrombin and Ten Phenolic Compounds by Affinity Capillary Electrophoresis and Molecular Docking. Li, Qiao-Qiao; Yang, Yu-Xiu; Qv, Jing-Wen; Hu, Guang; Hu, Yuan-Jia; Xia, Zhi-Ning; Yang, Feng-Qing Jan 1, 2018 4797
Corticobasal Syndrome Associated with Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus. Hashimoto, Ritsuo; Ogawa, Tomoko; Tagawa, Asako; Kato, Hiroyuki Jan 1, 2018 2167
First Reported Case of Hemopericardium Related to Dabigatran Use Reversed by New Antidote Idarucizumab. Song, Steven; Cook, Joselle; Goulbourne, Clive; Meade, Matthew; Salciccioli, Louis; Lazar, Jason Clinical report Jan 1, 2017 1997
Acute myocardial infarction after switching from warfarin to dabigatran. Abuzeid, Wael; Lawati, Hatim Al-; Fam, Neil Report Jan 1, 2015 2057
Economic appraisal of dabigatran as first-line therapy for stroke prevention in atrial fibrillation. Bergh, M.; Marais, C.A.; Miller-Janson, H.; Salie, F.; Stander, M.P. Apr 1, 2013 3720
Dabigatran's bleeding risk eyed. Brief article Jan 1, 2012 111
Dabigatran: a look before we leap. Masoodi, Naseer A.; Ahmad, Bilal Editorial Jun 1, 2011 1149
Pradaxa storage concerns. Brief article Apr 15, 2011 119
Time to try this warfarin alternative? Dabigatran appears to be as effective as warfarin in preventing stroke and thromboembolism in patients with atrial fibrillation--and is easier to use. Kirley, Kate; Rowland, Kate Apr 1, 2011 1649
Dabigatran added to atrial fibrillation guidelines. Splete, Heidi Brief article Mar 1, 2011 234
New anticlotting drug. Zipes, Douglas P. Brief article Jan 1, 2011 114
New oral anticoagulant wins approval from FDA. Nov 22, 2010 414
Panel OKs dabigatran to cut stroke risk in AF. Mechcatie, Elizabeth Oct 1, 2010 950

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |